Clinical Lecturer, Clinical Pharmacology and General Medicine
University of Nottingham and Nottingham University Hospitals NHS Trust
Mark Glover trained in pre-clinical pharmacology and clinical medicine at Gonville and Caius College, Cambridge. After clinical posts in Cambridge, Bedford and Nottingham he undertook a PhD in Clinical Pharmacology in Cambridge addressing the molecular mechanisms which regulate sodium trafficking in the distal nephron and which contribute to hypertension pathogenesis. His current research is focussed on the genetic basis of thiazide-induced hyponatraemia with clinical interests in hypertension, medical education and general (internal) medicine. He is a member of the MRCP (UK) Therapeutics group, is actively involved with therapeutics teaching, contributes to therapeutics textbooks and is an associate member of the Higher Education Academy. He has won young investigator prizes from the British Hypertension Society and has presented at meetings in Europe, North America and Australia.
Good clinical care and the safe use of medicines in practice is undermined by medication error. PSG001 (Technical patient safety solutions for medicines reconciliation on admission of adults to hospital) issued by NICE and the NPSA reflects the wealth of evidence suggesting that medication error frequently occurs at the time of admission of patients to hospital and is in many cases related to the quality of communication between primary and secondary care. Mark's NICE Scholarship, supervised by Dr Anette Freyer (Consultant in Acute Medicine and Clinical Pharmacology), will evaluate the impact of an initiative supported by the East Midlands Strategic Health Authority, Local Primary Care Trusts and Nottingham University Hospital's NHS Trust aimed at improving communication between the community and hospital. Specifically, a computer generated referral proforma, compatible with the principal systems in general practise promotes provision of a minimum dataset of information to accompany acute referrals of adult medical patients to hospital. The impact of the referral initiative and minimum dataset on the need for medicines reconciliation, medication error and health economies to the NHS will be assessed.
This page was last updated: 25 March 2011